Pulished Date August, 2019
ID: 212
Share on
Share on

Global Antifungal Drugs Market Analysis - By Drug Type (Echinocandins, Azoles, Polyenes, Allylamines, Other Drugs) By Therapeutic Indications (Aspergillosis, Dermatophytosis, Candidiasis, Other Therapeutic Indications), By Application (Powders, Ointments, Drugs, Pastes), By Region – Industry Size, Share, Trends, Growth, Forecast | 2019 - 2024

Pulished: August, 2019
ID: 212
Pages: 145

Global Antifungal Drugs Market Size & Growth (2019 - 2024)

As per our report, the market size of the Antifungal Drugs was worth USD 13.06 billion in 2018 and estimated to be growing at a CAGR of 3.68%, to reach USD 15.65 billion by 2024. The market is expected to grow enormously in the next few years, with the growing global population.

Antifungal drugs are mainly used to treat various infections like athlete’s foot, ringworm, candidiasis, and others. These drugs can be easily obtained through a doctor’s prescription whereas some are available over the counter. The drugs are manufactured with different formulas for various infections accordingly. Fungal infections are occurred due to the occurrence of organism feed by breaking down the living tissue which is also known as dermatophytes. They have the ability to utilize keratin and cause infection over skin, hair, and nails. The only aim of these drugs is to prevent the kill the fungal cell from growing by making the contents of the cell to break out. Unhygienic environments may lead to a severe condition in causing an infection on the skin.

Key Market Growth Drivers

Increasing awareness over the availability of the products through digital advertisements and campaigns is thriving the demand of the market majorly. Changes in the environmental conditions and rise in the spread of various infectious diseases from person to person are escalating the growth of the market. In addition, a growing number of fungal infections like aspergillosis and candidiasis is also propelling the demand of the market. The rise in the concern towards health is accelerating the growth of the antifungal drugs market. Increasing support from the government and non-government organizations over the antifungal diseases is driving the growth of the market eventually.

Major Challenges

However, the availability of alternate substitutes is silently hindering the growth of the market. The rise in side effects with long term use of these drugs is been challenging factor for the market growth. Also, fluctuations in the production rate of the drugs are slowly inhibiting the demand of the antifungal drugs market. Lack of skilled persons in manufacturing the drugs is also impeding the growth rate of the market. Stringent rules and regulations by the government in approving new drugs are also limiting the demand of the market.

Potential Opportunities

The adoption of latest technologies in producing various drugs and also offering effective treatment procedures for different infectious diseases across the world is to set up growth opportunities for the market. A rise in the demand to improve safety levels is lavishing the demand of this market. Furthermore, increasing investments in research and development institutes are ascribed to bolster the growth of the market.

REPORT COVERAGE

REPORT METRIC

DETAILS

Market Size Available

2018 – 2024

Base Year

2018

Forecast Period

2019 - 2024

Segments Covered

By Drug Type, Therapeutic Indications, Application and Region

Various Analyses Covered

Global, Regional & Country Level Analysis, Segment-Level Analysis, DROC, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities

Regions Covered

North America, Europe, APAC, Latin America, Middle East & Africa

Market Leaders Profiled

Gilead Sciences, Inc., Pfizer Inc., Sanofi S.A., Merck & Co., Inc., Novartis International AG, Abbott Laboratories, Bayer AG, Scynexis Inc., Enzon Pharmaceuticals, Inc. and GlaxoSmithKline Plc.

 

This market research report on Global Antifungal Drugs Market segmented and sub-segmented into the following categories and calculated market size and forecast for each segment until 2024.

Antifungal Drugs Market - By Drug Type

  • Echinocandins
  • Azoles
  • Polyenes
  • Allylamines
  • Others

On the basis of drug type, Echinocandins drug type is ruling with the highest shares of the market. The increasing scale of pharmaceutical industries is boosting up the demand of the market. Also, growing awareness camps through government organizations especially in rural areas are spurring the demand of this market.

Antifungal Drugs Market - By Therapeutic Indications

  • Aspergillosis
  • Dermatophytosis
  • Candidiasis
  • Others

Antifungal Drugs Market - By Application

  • Powders
  • Ointments
  • Drugs
  • Pastes

Based on the application, Growing knowledge over the dosage levels among physicians or doctors in hospitals is greatly influencing the demand of the market. The rise in the demand to increase productivity with growing incidences is likely to outshine the growth of the market.

Antifungal Drugs Market - By Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • The Middle East and Africa

North America is accounted for holding the largest shares of the market by owing to the acceptance of the latest technologies. The introduction of different types of drugs with high quality and low cost is prompting the growth rate of the market in this region. Europe is following North America in leading significant shares of the market. Rise in the capital income in most of the countries is straightly escalating the demand of the market. Also, increasing funds from private and public organizations to evaluate quality treatment procedures is surging the growth of the antifungal drugs market. Asia Pacific is witnessed in having a tremendous growth rate from recent years and is also deemed to have the highest CAGR in foreseen years. An increasing number of infectious disease cases due to unhygienic environments in rural areas is a major factor magnifying the growth of the market. Middle East and Africa are anticipated in having huge growth opportunities in the near future.

Noteworthy players in the Global Antifungal Drugs Market are:

  1. Gilead Sciences, Inc.
  2. Pfizer Inc.
  3. Sanofi S.A.
  4. Merck & Co., Inc.
  5. Novartis International AG
  6. Abbott Laboratories
  7. Bayer AG
  8. Scynexis Inc.
  9. Enzon Pharmaceuticals, Inc.
  10. GlaxoSmithKline Plc.
  1. Introduction
    1. Market Definition
    2. Study Deliverables
    3. Base Currency, Base Year and Forecast Periods
    4. General Study Assumptions
  2. Research Methodology
    1. Introduction
    2. Research Phases
      1. Secondary Research
      2. Primary Research
      3. Econometric Modelling
      4. Expert Validation
    3. Analysis Design
    4. Study Timeline
  3. Overview
    1. Executive Summary
    2. Key Inferences
    3. New Developments
  4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
    1. Market Drivers
    2. Market Restraints
    3. Key Challenges
    4. Current Opportunities in the Market
  5. Market Segmentation
    1. By Drug Type
      1. Echinocandins
      2. Azoles
      3. Polyenes
      4. Allylamines
      5. Others
    2. By Therapeutic Indications
      1. Aspergillosis
      2. Dermatophytosis
      3. Candidiasis
      4. Others
    3. By Application
      1. Powders
      2. Ointments
      3. Drugs
      4. Pasters
  6. Geographical Analysis
    1. North America
      1. Introduction
      2. United States
      3. Canada
    2. Europe
      1. Introduction
      2. U.K
      3. Spain
      4. Germany
      5. Italy
      6. France
    3. Asia-Pacific
      1. Introduction
      2. China
      3. India
      4. Japan
      5. South Korea
      6. Australia
    4. Latin America
      1. Introduction
      2. Brazil
      3. Argentina
      4. Mexico
      5. Rest of Latin America
    5. Middle East & Africa
      1. Introduction
      2. Middle East
      3. Africa
  7. Strategic Analysis
    1. PESTLE analysis
      1. Political
      2. Economic
      3. Social
      4. Technological
      5. Legal
      6. Environmental
    2. Porter’s Five analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Consumers
      3. Threat of New Entrants
      4. Threat of Substitute Products and Services
      5. Competitive Rivalry within the Industry
  8. Market Leaders' Analysis
    1. Alternaria
      1. Overview
      2. Product Analysis
      3. Strategic Evaluation and Operations
      4. Financial analysis
      5. Legal issues
      6. Recent Developments
      7. SWOT analysis
      8. Analyst View
    2. Pfizer
    3. Novartis
    4. Sanofi-Aventis
    5. Merck & Co.
    6. Asperqillus
    7. Kramer Laboratories
    8. Bayer Healthcare
    9. Enzon Pharmaceuticals
    10. Glaxosmithkline Gilead
    11. Abbott Laboratories
  9. Competitive Landscape
    1. Market share analysis
    2. Merger and Acquisition Analysis
    3.  Agreements, collaborations and Joint Ventures
    4. New Product Launches
  10. Expert Opinions
    1. Market Outlook
    2. Investment Opportunities
  • Global, regional, and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Antifungal Drugs Market By Region, From 2019 - 2024(USD Million)
  2. Antifungal Drugs Market By Drug Type, From 2019 - 2024(USD Million)
  3. Echinocandins Market By Region, From 2019 - 2024(USD Million)
  4. Azoles Market By Region, From 2019 - 2024(USD Million)
  5. Polyenes Market By Region, From 2019 - 2024(USD Million)
  6. Allylamines Market By Region, From 2019 - 2024(USD Million)
  7. Other Drugs Market By Region, From 2019 - 2024(USD Million)
  8. Antifungal Drugs Market By Therapeutic Indications, From 2019 - 2024(USD Million)
  9. Aspergillosis Market By Region, From 2019 - 2024(USD Million)
  10. Dermatophytosis Market By Region, From 2019 - 2024(USD Million)
  11. Candidiasis Market By Region, From 2019 - 2024(USD Million)
  12. Other Therapeutic Indications Market By Region, From 2019 - 2024(USD Million)
  13. Antifungal Drugs Market By Application, From 2019 - 2024(USD Million)
  14. Powders Market By Region, From 2019 - 2024(USD Million)
  15. Ointments Market By Region, From 2019 - 2024(USD Million)
  16. Drugs Market By Region, From 2019 - 2024(USD Million)
  17. Pastes Market By Region, From 2019 - 2024(USD Million)
  18. North America Antifungal Drugs Market By Region, From 2019 - 2024(USD Million)
  19. North America Antifungal Drugs Market By Drug Type, From 2019 - 2024(USD Million)
  20. North America Echinocandins Market By Region, From 2019 - 2024(USD Million)
  21. North America Azoles Market By Region, From 2019 - 2024(USD Million)
  22. North America Polyenes Market By Region, From 2019 - 2024(USD Million)
  23. North America Allylamines Market By Region, From 2019 - 2024(USD Million)
  24. North America Other Drugs Market By Region, From 2019 - 2024(USD Million)
  25. North America Antifungal Drugs Market By Therapeutic Indications, From 2019 - 2024(USD Million)
  26. North America Aspergillosis Market By Region, From 2019 - 2024(USD Million)
  27. North America Dermatophytosis Market By Region, From 2019 - 2024(USD Million)
  28. North America Candidiasis Market By Region, From 2019 - 2024(USD Million)
  29. North America Other Therapeutic Indications Market By Region, From 2019 - 2024(USD Million)
  30. North America Antifungal Drugs Market By Application, From 2019 - 2024(USD Million)
  31. North America Powders Market By Region, From 2019 - 2024(USD Million)
  32. North America Ointments Market By Region, From 2019 - 2024(USD Million)
  33. North America Drugs Market By Region, From 2019 - 2024(USD Million)
  34. North America Pastes Market By Region, From 2019 - 2024(USD Million)
  35. United States Antifungal Drugs Market By Drug Type, From 2019 - 2024(USD Million)
  36. United States Antifungal Drugs Market By Therapeutic Indications, From 2019 - 2024(USD Million)
  37. United States Antifungal Drugs Market By Application, From 2019 - 2024(USD Million)
  38. Canada Antifungal Drugs Market By Drug Type, From 2019 - 2024(USD Million)
  39. Canada Antifungal Drugs Market By Therapeutic Indications, From 2019 - 2024(USD Million)
  40. Canada Antifungal Drugs Market By Application, From 2019 - 2024(USD Million)
  41. Europe Antifungal Drugs Market By Region, From 2019 - 2024(USD Million)
  42. Europe Antifungal Drugs Market By Drug Type, From 2019 - 2024(USD Million)
  43. Europe Echinocandins Market By Region, From 2019 - 2024(USD Million)
  44. Europe Azoles Market By Region, From 2019 - 2024(USD Million)
  45. Europe Polyenes Market By Region, From 2019 - 2024(USD Million)
  46. Europe Allylamines Market By Region, From 2019 - 2024(USD Million)
  47. Europe Other Drugs Market By Region, From 2019 - 2024(USD Million)
  48. Europe Antifungal Drugs Market By Therapeutic Indications, From 2019 - 2024(USD Million)
  49. Europe Aspergillosis Market By Region, From 2019 - 2024(USD Million)
  50. Europe Dermatophytosis Market By Region, From 2019 - 2024(USD Million)
  51. Europe Candidiasis Market By Region, From 2019 - 2024(USD Million)
  52. Europe Other Therapeutic Indications Market By Region, From 2019 - 2024(USD Million)
  53. Europe Antifungal Drugs Market By Application, From 2019 - 2024(USD Million)
  54. Europe Powders Market By Region, From 2019 - 2024(USD Million)
  55. Europe Ointments Market By Region, From 2019 - 2024(USD Million)
  56. Europe Drugs Market By Region, From 2019 - 2024(USD Million)
  57. Europe Pastes Market By Region, From 2019 - 2024(USD Million)
  58. U.K Antifungal Drugs Market By Drug Type, From 2019 - 2024(USD Million)
  59. U.K Antifungal Drugs Market By Therapeutic Indications, From 2019 - 2024(USD Million)
  60. U.K Antifungal Drugs Market By Application, From 2019 - 2024(USD Million)
  61. Spain Antifungal Drugs Market By Drug Type, From 2019 - 2024(USD Million)
  62. Spain Antifungal Drugs Market By Therapeutic Indications, From 2019 - 2024(USD Million)
  63. Spain Antifungal Drugs Market By Application, From 2019 - 2024(USD Million)
  64. Germany Antifungal Drugs Market By Drug Type, From 2019 - 2024(USD Million)
  65. Germany Antifungal Drugs Market By Therapeutic Indications, From 2019 - 2024(USD Million)
  66. Germany Antifungal Drugs Market By Application, From 2019 - 2024(USD Million)
  67. Italy Antifungal Drugs Market By Drug Type, From 2019 - 2024(USD Million)
  68. Italy Antifungal Drugs Market By Therapeutic Indications, From 2019 - 2024(USD Million)
  69. Italy Antifungal Drugs Market By Application, From 2019 - 2024(USD Million)
  70. France Antifungal Drugs Market By Drug Type, From 2019 - 2024(USD Million)
  71. France Antifungal Drugs Market By Therapeutic Indications, From 2019 - 2024(USD Million)
  72. France Antifungal Drugs Market By Application, From 2019 - 2024(USD Million)
  73. Asia-Pacific Antifungal Drugs Market By Region, From 2019 - 2024(USD Million)
  74. Asia-Pacific Antifungal Drugs Market By Drug Type, From 2019 - 2024(USD Million)
  75. Asia-Pacific Echinocandins Market By Region, From 2019 - 2024(USD Million)
  76. Asia-Pacific Azoles Market By Region, From 2019 - 2024(USD Million)
  77. Asia-Pacific Polyenes Market By Region, From 2019 - 2024(USD Million)
  78. Asia-Pacific Allylamines Market By Region, From 2019 - 2024(USD Million)
  79. Asia-Pacific Other Drugs Market By Region, From 2019 - 2024(USD Million)
  80. Asia-Pacific Antifungal Drugs Market By Therapeutic Indications, From 2019 - 2024(USD Million)
  81. Asia-Pacific Aspergillosis Market By Region, From 2019 - 2024(USD Million)
  82. Asia-Pacific Dermatophytosis Market By Region, From 2019 - 2024(USD Million)
  83. Asia-Pacific Candidiasis Market By Region, From 2019 - 2024(USD Million)
  84. Asia-Pacific Other Therapeutic Indications Market By Region, From 2019 - 2024(USD Million)
  85. Asia-Pacific Antifungal Drugs Market By Application, From 2019 - 2024(USD Million)
  86. Asia-Pacific Powders Market By Region, From 2019 - 2024(USD Million)
  87. Asia-Pacific Ointments Market By Region, From 2019 - 2024(USD Million)
  88. Asia-Pacific Drugs Market By Region, From 2019 - 2024(USD Million)
  89. Asia-Pacific Pastes Market By Region, From 2019 - 2024(USD Million)
  90. China Antifungal Drugs Market By Drug Type, From 2019 - 2024(USD Million)
  91. China Antifungal Drugs Market By Therapeutic Indications, From 2019 - 2024(USD Million)
  92. China Antifungal Drugs Market By Application, From 2019 - 2024(USD Million)
  93. India Antifungal Drugs Market By Drug Type, From 2019 - 2024(USD Million)
  94. India Antifungal Drugs Market By Therapeutic Indications, From 2019 - 2024(USD Million)
  95. India Antifungal Drugs Market By Application, From 2019 - 2024(USD Million)
  96. Japan Antifungal Drugs Market By Drug Type, From 2019 - 2024(USD Million)
  97. Japan Antifungal Drugs Market By Therapeutic Indications, From 2019 - 2024(USD Million)
  98. Japan Antifungal Drugs Market By Application, From 2019 - 2024(USD Million)
  99. South Korea Antifungal Drugs Market By Drug Type, From 2019 - 2024(USD Million)
  100. South Korea Antifungal Drugs Market By Therapeutic Indications, From 2019 - 2024(USD Million)
  101. South Korea Antifungal Drugs Market By Application, From 2019 - 2024(USD Million)
  102. Australia Antifungal Drugs Market By Drug Type, From 2019 - 2024(USD Million)
  103. Australia Antifungal Drugs Market By Therapeutic Indications, From 2019 - 2024(USD Million)
  104. Australia Antifungal Drugs Market By Application, From 2019 - 2024(USD Million)
  105. Latin America Antifungal Drugs Market By Region, From 2019 - 2024(USD Million)
  106. Latin America Antifungal Drugs Market By Drug Type, From 2019 - 2024(USD Million)
  107. Latin America Echinocandins Market By Region, From 2019 - 2024(USD Million)
  108. Latin America Azoles Market By Region, From 2019 - 2024(USD Million)
  109. Latin America Polyenes Market By Region, From 2019 - 2024(USD Million)
  110. Latin America Allylamines Market By Region, From 2019 - 2024(USD Million)
  111. Latin America Other Drugs Market By Region, From 2019 - 2024(USD Million)
  112. Latin America Antifungal Drugs Market By Therapeutic Indications, From 2019 - 2024(USD Million)
  113. Latin America Aspergillosis Market By Region, From 2019 - 2024(USD Million)
  114. Latin America Dermatophytosis Market By Region, From 2019 - 2024(USD Million)
  115. Latin America Candidiasis Market By Region, From 2019 - 2024(USD Million)
  116. Latin America Other Therapeutic Indications Market By Region, From 2019 - 2024(USD Million)
  117. Latin America Antifungal Drugs Market By Application, From 2019 - 2024(USD Million)
  118. Latin America Powders Market By Region, From 2019 - 2024(USD Million)
  119. Latin America Ointments Market By Region, From 2019 - 2024(USD Million)
  120. Latin America Drugs Market By Region, From 2019 - 2024(USD Million)
  121. Latin America Pastes Market By Region, From 2019 - 2024(USD Million)
  122. Brazil Antifungal Drugs Market By Drug Type, From 2019 - 2024(USD Million)
  123. Brazil Antifungal Drugs Market By Therapeutic Indications, From 2019 - 2024(USD Million)
  124. Brazil Antifungal Drugs Market By Application, From 2019 - 2024(USD Million)
  125. Argentina Antifungal Drugs Market By Drug Type, From 2019 - 2024(USD Million)
  126. Argentina Antifungal Drugs Market By Therapeutic Indications, From 2019 - 2024(USD Million)
  127. Argentina Antifungal Drugs Market By Application, From 2019 - 2024(USD Million)
  128. Mexico Antifungal Drugs Market By Drug Type, From 2019 - 2024(USD Million)
  129. Mexico Antifungal Drugs Market By Therapeutic Indications, From 2019 - 2024(USD Million)
  130. Mexico Antifungal Drugs Market By Application, From 2019 - 2024(USD Million)
  131. Rest of Latin America Antifungal Drugs Market By Drug Type, From 2019 - 2024(USD Million)
  132. Rest of Latin America Antifungal Drugs Market By Therapeutic Indications, From 2019 - 2024(USD Million)
  133. Rest of Latin America Antifungal Drugs Market By Application, From 2019 - 2024(USD Million)
  134. Middle East & Africa Antifungal Drugs Market By Region, From 2019 - 2024(USD Million)
  135. Middle East & Africa Antifungal Drugs Market By Drug Type, From 2019 - 2024(USD Million)
  136. Middle East & Africa Echinocandins Market By Region, From 2019 - 2024(USD Million)
  137. Middle East & Africa Azoles Market By Region, From 2019 - 2024(USD Million)
  138. Middle East & Africa Polyenes Market By Region, From 2019 - 2024(USD Million)
  139. Middle East & Africa Allylamines Market By Region, From 2019 - 2024(USD Million)
  140. Middle East & Africa Other Drugs Market By Region, From 2019 - 2024(USD Million)
  141. Middle East & Africa Antifungal Drugs Market By Therapeutic Indications, From 2019 - 2024(USD Million)
  142. Middle East & Africa Aspergillosis Market By Region, From 2019 - 2024(USD Million)
  143. Middle East & Africa Dermatophytosis Market By Region, From 2019 - 2024(USD Million)
  144. Middle East & Africa Candidiasis Market By Region, From 2019 - 2024(USD Million)
  145. Middle East & Africa Other Therapeutic Indications Market By Region, From 2019 - 2024(USD Million)
  146. Middle East & Africa Antifungal Drugs Market By Application, From 2019 - 2024(USD Million)
  147. Middle East & Africa Powders Market By Region, From 2019 - 2024(USD Million)
  148. Middle East & Africa Ointments Market By Region, From 2019 - 2024(USD Million)
  149. Middle East & Africa Drugs Market By Region, From 2019 - 2024(USD Million)
  150. Middle East & Africa Pastes Market By Region, From 2019 - 2024(USD Million)
  151. Middle East Antifungal Drugs Market By Drug Type, From 2019 - 2024(USD Million)
  152. Middle East Antifungal Drugs Market By Therapeutic Indications, From 2019 - 2024(USD Million)
  153. Middle East Antifungal Drugs Market By Application, From 2019 - 2024(USD Million)
  154. Africa Antifungal Drugs Market By Drug Type, From 2019 - 2024(USD Million)
  155. Africa Antifungal Drugs Market By Therapeutic Indications, From 2019 - 2024(USD Million)
  156. Africa Antifungal Drugs Market By Application, From 2019 - 2024(USD Million)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 4255

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample